CM Ingerman

837 total citations
9 papers, 675 citations indexed

About

CM Ingerman is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, CM Ingerman has authored 9 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 4 papers in Cardiology and Cardiovascular Medicine and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in CM Ingerman's work include Inflammatory mediators and NSAID effects (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Adenosine and Purinergic Signaling (2 papers). CM Ingerman is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Adenosine and Purinergic Signaling (2 papers). CM Ingerman collaborates with scholars based in United States. CM Ingerman's co-authors include M.J. Silver, J B Smith, J. Bryan Smith, James J. Kocsis, Sandor S. Shapiro, MJ Silver, Albert W. Sedar, Mark Nissenbaum and Smith Jb and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Advances in experimental medicine and biology.

In The Last Decade

CM Ingerman

9 papers receiving 603 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
CM Ingerman United States	6	280	229	127	118	94	9	675
Carol M. Ingerman United States	12	617 2.2×	443 1.9×	128 1.0×	249 2.1×	160 1.7×	18	1.1k
G A FitzGerald United States	10	329 1.2×	294 1.3×	53 0.4×	198 1.7×	180 1.9×	14	888
J B Smith United States	6	129 0.5×	169 0.7×	56 0.4×	46 0.4×	76 0.8×	6	537
C Lechi Italy	16	140 0.5×	231 1.0×	38 0.3×	91 0.8×	122 1.3×	45	657
Giovanni DiMinno Italy	8	86 0.3×	166 0.7×	186 1.5×	66 0.6×	92 1.0×	9	669
E Marcinkiewicz Poland	14	189 0.7×	196 0.9×	44 0.3×	99 0.8×	177 1.9×	31	686
Maurizio Degan Italy	20	184 0.7×	345 1.5×	69 0.5×	185 1.6×	326 3.5×	58	1.2k
Victor Skrinska United States	16	97 0.3×	115 0.5×	26 0.2×	73 0.6×	110 1.2×	32	547
K. Stegmeier Germany	13	115 0.4×	115 0.5×	39 0.3×	78 0.7×	294 3.1×	29	577
Janet D. Peller United States	9	92 0.3×	56 0.2×	50 0.4×	58 0.5×	202 2.1×	10	501

Countries citing papers authored by CM Ingerman

Since Specialization

Citations

This map shows the geographic impact of CM Ingerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CM Ingerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CM Ingerman more than expected).

Fields of papers citing papers by CM Ingerman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by CM Ingerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CM Ingerman. The network helps show where CM Ingerman may publish in the future.

Co-authorship network of co-authors of CM Ingerman

This figure shows the co-authorship network connecting the top 25 collaborators of CM Ingerman. A scholar is included among the top collaborators of CM Ingerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with CM Ingerman. CM Ingerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Nissenbaum, Mark, et al.. (1980). A model system for studying initial events in atherosclerosis.. PubMed. 8(1). 80–4. 4 indexed citations

2.

Smith, J. Bryan, CM Ingerman, & M.J. Silver. (1978). Drug Effects on Platelet Aggregation and Prostaglandin Formation. Advances in experimental medicine and biology. 109. 239–251. 1 indexed citations

3.

Ingerman, CM, J. Bryan Smith, Sandor S. Shapiro, Albert W. Sedar, & MJ Silver. (1978). Hereditary abnormality of platelet aggregation attributable to nucleotide storage pool deficiency. Blood. 52(2). 332–344. 40 indexed citations

4.

Ingerman, CM, et al.. (1978). Hereditary abnormality of platelet aggregation attributable to nucleotide storage pool deficiency. Blood. 52(2). 332–344. 30 indexed citations

5.

Smith, J B, CM Ingerman, & M.J. Silver. (1976). Malondialdehyde formation as an indicator of prostaglandin production by human platelets.. PubMed. 88(1). 167–72. 313 indexed citations

6.

Smith, J. Bryan, CM Ingerman, & M.J. Silver. (1976). Persistence of thromboxane A2-like material and platelet release-inducing activity in plasma.. Journal of Clinical Investigation. 58(5). 1119–1122. 47 indexed citations

7.

Smith, J. Bryan, M.J. Silver, CM Ingerman, & James J. Kocsis. (1975). Uptake and inactivation of a-type prostaglandins by human red cells. Prostaglandins. 9(1). 135–145. 22 indexed citations

8.

Silver, M.J., J. Bryan Smith, CM Ingerman, & James J. Kocsis. (1973). Arachidonic acid-induced human platelet aggregation and prostaglandin formation. Prostaglandins. 4(6). 863–875. 216 indexed citations

9.

Silver, M.J., J. Bryan Smith, CM Ingerman, & James J. Kocsis. (1972). Letters to the editor. Prostaglandins. 2(2). 75–77. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact